Whitney H, Yoeli-Bik R, Abramowicz J, Lan L, Li H, Longman R
J Med Imaging (Bellingham). 2024; 11(4):044505.
PMID: 39114540
PMC: 11301525.
DOI: 10.1117/1.JMI.11.4.044505.
Yang Y, Long H, Feng Y, Tian S, Chen H, Zhou P
Heliyon. 2024; 10(11):e32115.
PMID: 38947468
PMC: 11214460.
DOI: 10.1016/j.heliyon.2024.e32115.
Yoo H, Cho K, Song S, Cho Y, Jung S, Sung K
Diagnostics (Basel). 2023; 13(23).
PMID: 38066810
PMC: 10706613.
DOI: 10.3390/diagnostics13233569.
Fawaz A, Ferraresi A, Isidoro C
J Pers Med. 2023; 13(11).
PMID: 38003905
PMC: 10672164.
DOI: 10.3390/jpm13111590.
Whitney H, Drukker K, Vieceli M, Van Dusen A, de Oliveira M, Abe H
Med Phys. 2023; 51(3):1812-1821.
PMID: 37602841
PMC: 10879454.
DOI: 10.1002/mp.16673.
Differences in Molecular Subtype Reference Standards Impact AI-based Breast Cancer Classification with Dynamic Contrast-enhanced MRI.
Ji Y, Whitney H, Li H, Liu P, Giger M, Zhang X
Radiology. 2023; 307(1):e220984.
PMID: 36594836
PMC: 10068887.
DOI: 10.1148/radiol.220984.
Criteria for the translation of radiomics into clinically useful tests.
Huang E, OConnor J, McShane L, Giger M, Lambin P, Kinahan P
Nat Rev Clin Oncol. 2022; 20(2):69-82.
PMID: 36443594
PMC: 9707172.
DOI: 10.1038/s41571-022-00707-0.
Effect of biopsy on the MRI radiomics classification of benign lesions and luminal A cancers.
Whitney H, Drukker K, Edwards A, Papaioannou J, Giger M
J Med Imaging (Bellingham). 2022; 6(3):031408.
PMID: 35834307
PMC: 6378704.
DOI: 10.1117/1.JMI.6.3.031408.
A machine-learning algorithm for distinguishing malignant from benign indeterminate thyroid nodules using ultrasound radiomic features.
Keutgen X, Li H, Memeh K, Conn Busch J, Williams J, Lan L
J Med Imaging (Bellingham). 2022; 9(3):034501.
PMID: 35692282
PMC: 9133922.
DOI: 10.1117/1.JMI.9.3.034501.
Impact of continuous learning on diagnostic breast MRI AI: evaluation on an independent clinical dataset.
Li H, Whitney H, Ji Y, Edwards A, Papaioannou J, Liu P
J Med Imaging (Bellingham). 2022; 9(3):034502.
PMID: 35685120
PMC: 9168763.
DOI: 10.1117/1.JMI.9.3.034502.
Performance metric curve analysis framework to assess impact of the decision variable threshold, disease prevalence, and dataset variability in two-class classification.
Whitney H, Drukker K, Giger M
J Med Imaging (Bellingham). 2022; 9(3):035502.
PMID: 35656541
PMC: 9152992.
DOI: 10.1117/1.JMI.9.3.035502.
Bone Cancer Detection Using Feature Extraction Based Machine Learning Model.
Sharma A, Yadav D, Garg H, Kumar M, Sharma B, Koundal D
Comput Math Methods Med. 2021; 2021:7433186.
PMID: 34966444
PMC: 8712164.
DOI: 10.1155/2021/7433186.
Association between breast cancer's prognostic factors and 3D textural features of non-contrast-enhanced weighted breast MRI.
Lepola A, Arponen O, Okuma H, Holli-Helenius K, Junkkari H, Kononen M
Br J Radiol. 2021; 95(1130):20210702.
PMID: 34826254
PMC: 8822552.
DOI: 10.1259/bjr.20210702.
Computer-assisted quantification of tumor-associated collagen signatures to improve the prognosis prediction of breast cancer.
Xi G, Qiu L, Xu S, Guo W, Fu F, Kang D
BMC Med. 2021; 19(1):273.
PMID: 34789257
PMC: 8600902.
DOI: 10.1186/s12916-021-02146-7.
MRI-Based Machine Learning in Differentiation Between Benign and Malignant Breast Lesions.
Zhao Y, Chen R, Zhang T, Chen C, Muhelisa M, Huang J
Front Oncol. 2021; 11:552634.
PMID: 34733774
PMC: 8558475.
DOI: 10.3389/fonc.2021.552634.
Clinical Artificial Intelligence Applications: Breast Imaging.
Hu Q, Giger M
Radiol Clin North Am. 2021; 59(6):1027-1043.
PMID: 34689871
PMC: 9075017.
DOI: 10.1016/j.rcl.2021.07.010.
Multi-Stage Harmonization for Robust AI across Breast MR Databases.
Whitney H, Li H, Ji Y, Liu P, Giger M
Cancers (Basel). 2021; 13(19).
PMID: 34638294
PMC: 8508003.
DOI: 10.3390/cancers13194809.
MRI texture features from tumor core and margin in the prediction of response to neoadjuvant chemotherapy in patients with locally advanced breast cancer.
Kolios C, Sannachi L, Dasgupta A, Suraweera H, DiCenzo D, Stanisz G
Oncotarget. 2021; 12(14):1354-1365.
PMID: 34262646
PMC: 8274727.
DOI: 10.18632/oncotarget.28002.
Robustness of radiomic features of benign breast lesions and hormone receptor positive/HER2-negative cancers across DCE-MR magnet strengths.
Whitney H, Drukker K, Edwards A, Papaioannou J, Medved M, Karczmar G
Magn Reson Imaging. 2021; 82:111-121.
PMID: 34174331
PMC: 8386988.
DOI: 10.1016/j.mri.2021.06.021.
Label-free identification of human coronary atherosclerotic plaque based on a three-dimensional quantitative assessment of multiphoton microscopy images.
Zhang R, Xu Z, Hao J, Yu J, Liu Z, Liu S
Biomed Opt Express. 2021; 12(5):2979-2995.
PMID: 34168910
PMC: 8194630.
DOI: 10.1364/BOE.422525.